Sprint Bioscience AB
F:5JA1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sprint Bioscience AB
F:5JA1
|
SE |
|
C
|
Compass Group PLC
OTC:CMPGF
|
UK |
|
C
|
China Petroleum & Chemical Corp
XMUN:CHU
|
CN |
|
L
|
L'Oreal SA
XHAM:LOR
|
FR |
|
O
|
Orlen SA
SWB:PKY1
|
PL |
|
M
|
Morgan Stanley
F:DWD
|
US |
|
E
|
Ecolab Inc
XBER:ECJ
|
US |
|
Elicio Therapeutics Inc
F:9HA
|
US |
|
S
|
Swiss Prime Site AG
XMUN:SU1N
|
CH |
|
Oxford Instruments PLC
F:OX3
|
UK |
|
Zinc One Resources Inc
F:RH3
|
CA |
|
K
|
King River Resources Ltd
XBER:34N
|
AU |
|
D
|
Draganfly Inc
F:3U8A
|
CA |
|
C
|
Cintas Corp
F:CIT
|
US |
|
P
|
Perusahaan Gas Negara Tbk PT
XMUN:PGB1
|
ID |
|
A
|
Aiful Corp
F:AAU
|
JP |
|
Bowen Coking Coal Ltd
ASX:BCBDB
|
AU |
|
A
|
Axon Enterprise Inc
XBER:TCS
|
US |
|
M
|
Molina Healthcare Inc
F:MHG
|
US |
|
AB Science SA
PAR:AB
|
FR |
|
B
|
Barclays PLC
F:BCY
|
UK |
|
G
|
Glencore PLC
F:8GCA
|
CH |
|
T
|
Teradyne Inc
LSE:0LEF
|
US |
|
M
|
Mogo Inc
TSX:ORIO
|
CA |
Bankruptcy Probability
Sprint Bioscience AB's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sprint Bioscience AB Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
S
|
Sprint Bioscience AB
STO:SPRINT
|
386.2m SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
358.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sprint Bioscience AB's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sprint Bioscience AB has no debt.
You can find a full breakdown on its Balance Sheet.
